Bruker Corporation (BRKR)
| Market Cap | 12.32B |
| Revenue (ttm) | 2.12B |
| Net Income (ttm) | 204.00M |
| Shares Out | 151.80M |
| EPS (ttm) | 1.32 |
| PE Ratio | 61.21 |
| Forward PE | 46.73 |
| Dividend | $0.16 |
| Dividend Yield | 0.20% |
| Trading Day | July 26 |
| Last Price | $80.86 |
| Previous Close | $82.35 |
| Change ($) | -1.49 |
| Change (%) | -1.81% |
| Day's Open | 82.28 |
| Day's Range | 80.77 - 82.66 |
| Day's Volume | 645,447 |
| 52-Week Range | 37.19 - 82.76 |
Bruker (BRKR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2021 financial results on Monday, August 2, 2021, after the market closes. The Company ...
Bruker (BRKR) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Bruker (BRKR) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BILLERICA, Mass.--(BUSINESS WIRE)--At Bruker's virtual 4D-Metabolomics™ eXceed Symposium (eXceed Symposia 4D-Metabolomics 2021 | Bruker), Bruker Corporation (Nasdaq: BRKR) today announced the launch of ...
Bruker (BRKR) updates 2021 financial guidance encouraged by solid business growth and high-growth opportunities.
At its 2021 Virtual Investor Day, Bruker Corporation (NASDAQ: BRKR) raised the 2021 outlook boosted by its first-quarter solid performance. For 2021, Bruker expects revenue growth of approximately 16-18...
Investors are optimistic about Bruker (BRKR) on solid CALID Group growth potential and raised 2021 financial guidance.
BILLERICA, Mass.--(BUSINESS WIRE)--At its 2021 Virtual Investor Day today, Bruker Corporation (Nasdaq: BRKR) will discuss the Company's strategy and Project Accelerate 2.0 initiatives, including the Com...
Bruker's (BRKR) FluoroType SARS-CoV-2 varID Q assay differentiates and quantifies the SARS-CoV-2 virus in just one PCR test, thereby reducing workload, cost, and time.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) will host a Virtual Investor Day on June 17th, 2021, starting at 10:00 AM Eastern Daylight Time. The Investor Day will be in a virtua...
NEHREN, Germany--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced the launch of the FluoroType SARS-CoV-2 varID Q assay – a quantitative LiquidArray® mid-plex PCR panel. This novel ass...
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
BILLERICA, Mass.--(BUSINESS WIRE)--At Bruker's virtual 4D-Proteomics™ eXceed Symposium (eXceed Symposia 2021 | Bruker), Bruker Corporation (Nasdaq: BRKR) today announced the launch of two new timsTOF in...
Does Bruker (BRKR) have what it takes to be a top stock pick for momentum investors? Let's find out.
3 Stocks to Watch on Rising Demand for Scientific Instruments
Bruker (BRKR) could produce exceptional returns because of its solid growth attributes.
Discovering new insights into Covid-19, particularly 'long Covid', InMode and Idexx peer Bruker continues to test new buy point. The post InMode, Idexx Peer Bruker Tests Buy Zone With New Insights Into ...
Bruker's (BRKR) quantitative NMR and MS assay platform together with Australian National Phenome Centre evaluate risk and longitudinal monitoring of post-acute COVID-19 syndrome.
PERTH, Australia--(BUSINESS WIRE)--A clinical research collaboration on COVID-19 pheno-conversion and subsequent pheno-reversion has discovered transient and persistent systemic changes of the molecular...
Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.
BILERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced that on May 12, 2021, its Board of Directors approved a new share repurchase authorization for the purchase of up to $...
We have narrowed down our search to five growth stocks that have popped more than 25 % year to date and still have upside left for 2021. These are: UPS, CLR, MOH, CDW, and BRKR
ETTLINGEN, Germany--(BUSINESS WIRE)--Nuclear magnetic resonance (NMR) spectroscopy has been incorporated by the intergovernmental and International Organization of Vine and Wine (OIV) in its compendium ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) announced today it will participate in the following virtual conferences: BofA Securities 2021 Health Care Conference Tuesday, May 11...
Bruker (BRKR) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Bruker's (BRKR) robust performances across segments and geographies manage to drive its Q1 sales despite pandemic-led business challenges.
Bruker Corp (NASDAQ: BRKR) reported first-quarter FY21 revenue growth of 30.8% year-on-year to $554.7 million, beating the analyst consensus of $513.06 million. Revenue increased by 23.8% on an organic ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2021. First Quarter 2021 Financial Results Bruker's revenues ...
Bruker's (BRKR) revenue improvement in the first quarter is likely to have been boosted by robust performance by all three of its BSI groups.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) today announced preliminary revenue for the first quarter ended March 31, 2021 in a range of $549 - $554 million, representing report...
Indexes Make Up Lost Ground; Strong Moves In Nvidia and Yeti, Bruker Sets Up
Indexes make up lost ground; Strong moves in Nvidia and Yeti, Bruker sets up. Investor's Business Daily has been helping people invest smarter results by providing exclusive stock lists, investing data,...
Investors continue to be optimistic about Bruker (BRKR) on its slew of product launches and potential in the BSI Nano Group.
BILLERICA, Mass.--(BUSINESS WIRE)--Gigahertz-class NMR Opens New Scientific Windows on Functional Structural Biology in Neurodegenerative Disease and Aging Research
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Makes Routine Magnetic Resonance Spectroscopy More Broadly Accessible for Chemical Analysis Outside Central Labs
NEW YORK--(BUSINESS WIRE)--Bruker Light-Sheet Microscopes at Major Comprehensive Cancer Center
Bruker (BRKR) reported earnings 30 days ago. What's next for the stock?
SAN JOSE, Calif. & BOSTON--(BUSINESS WIRE)--Acuity Spatial Genomics Announces Formation to Open up New Frontiers for in situ, Spatial 3D Genomics
Bruker Corp (BRKR) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
CHARLESTON, S.C., March 10, 2021 /PRNewswire/ -- GlycoPath Inc., the developer of advanced bioanalytical assays based on its proprietary GlycoTyperTM immunoaffinity technology, announced the closing of ...
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces New Results in Deep, Unbiased Plasma Proteomics, PaSER 1.1 Software and New Cross-linking Consumables at US HUPO 2021
MUNICH--(BUSINESS WIRE)--Nature Communications Publication by Mann & Theis Groups Harnesses the Benefits of Large-scale Peptide Collisional Cross Section (CCS) Measurement
Within Bruker's (BRKR) Nano Group Semiconductor metrology revenues have been steady with order rates improving as semi metrology equipment markets are witnessing a rebound.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Corporation to Present at Investor Conferences
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Announces Quarterly Dividend
Bruker's (BRKR) revenues increased 4.6% year over year to $627.5 million but declined 0.4% organically in fourth-quarter fiscal 2020.
BILLERICA, Mass.--(BUSINESS WIRE)--Bruker Reports Fourth Quarter and Fiscal Year 2020 Financial Results
Bruker (NASDAQ:BRKR) unveils its next round of earnings this Tuesday, February 16. Get prepared with Benzinga's ultimate preview for Bruker's Q4 earnings.
Bruker (BRKR) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
About BRKR
Bruker Corporation develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally. The company operates through three segments: Bruker Scientific Instruments (BSI) Life Science, BSI NANO, and Bruker Energy & Supercon Technologies. It offers life science tools based on magnetic resonance technology; life science mass spectrometry and ion mobility spectrometry solutions; analytical and process analysis instruments and solutions based on in... [Read more...]
| Industry Medical Devices | IPO Date Aug 4, 2000 |
| CEO Frank Laukien | Employees 7,400 |
| Stock Exchange NASDAQ | Ticker Symbol BRKR |
Financial Performance
In 2020, Bruker's revenue was $1.99 billion, a decrease of -4.11% compared to the previous year's $2.07 billion. Earnings were $157.80 million, a decrease of -19.98%.
Analyst Forecasts
According to 13 analysts, the average rating for Bruker stock is "Buy." The 12-month stock price forecast is 75.50, which is a decrease of -6.63% from the latest price.